Blackstone Inc’s Epizyme, Inc EPZM Stock Holding History

Blackstone Inc’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-520	Closed	-$14K	–	62
2014 Q3	$14K	Buy	+520	New	+$16.2K	﹤0.01%	50

Other funds holding EPZM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Blackstone Inc's EPZM Position: Q4 2014 in Review

Blackstone Inc sold out of Epizyme, Inc (EPZM) in Q4 2014, closing a stake of 520 shares — an estimated $14K sold.

Blackstone Inc first reported a position in EPZM in Q3 2014 and held it in 1 quarter. The position peaked at $14K in Q3 2014. 82 funds tracked by Wall St. Rank hold EPZM as of Q4 2014.

Blackstone Inc reported no remaining Epizyme, Inc position as of Q4 2014 after selling out during the quarter.
Blackstone Inc sold 520 Epizyme, Inc shares in Q4 2014, an estimated $14K.
Blackstone Inc first reported a position in Epizyme, Inc in Q3 2014 and held it in 1 quarter.
Blackstone Inc's Epizyme, Inc position peaked at $14K in Q3 2014.
82 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2014.

Based on Blackstone Inc's 13F filing for Q4 2014, filed 17 Feb 2015.